Daito Pharmaceutical Co Ltd (4577)

Currency in JPY
1,292.0
+19.0(+1.49%)
Delayed Data·
4577 Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
4577 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,273.01,296.0
52 wk Range
970.02,465.0
Key Statistics
Bid/Ask
1,290.00 / 1,293.00
Prev. Close
1,273
Open
1,280
Day's Range
1,273-1,296
52 wk Range
970-2,465
Volume
12.4K
Average Volume (3m)
87.19K
1-Year Change
-46.51%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4577 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,150.0
Downside
-10.99%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Daito Pharmaceutical Co Ltd Company Profile

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Employees
1070
Market
Japan

Compare 4577 to Peers and Sector

Metrics to compare
4577
Peers
Sector
Relationship
P/E Ratio
20.0x12.7x−0.6x
PEG Ratio
−0.500.170.00
Price/Book
0.7x1.0x2.6x
Price / LTM Sales
0.8x1.4x3.3x
Upside (Analyst Target)
−9.7%14.4%40.2%
Fair Value Upside
Unlock13.5%5.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1,150.0
(-10.99% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 62.72%
Dividend Yield
4.12%
Industry Median 2.48%
Annualised payout
52.50
Paid unevenly
5-Years Growth
+14.00%
Growth Streak

Earnings

Latest Release
Jul 11, 2025
EPS / Forecast
22.88 / --
Revenue / Forecast
14.03B / 13.05B
EPS Revisions
Last 90 days

4577 Income Statement

FAQ

What Stock Exchange Does Daito Pharmaceutical Trade On?

Daito Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Daito Pharmaceutical?

The stock symbol for Daito Pharmaceutical is "4577."

What Is the Daito Pharmaceutical Market Cap?

As of today, Daito Pharmaceutical market cap is 38.77B.

What Is Daito Pharmaceutical's Earnings Per Share (TTM)?

The Daito Pharmaceutical EPS (TTM) is 62.72.

When Is the Next Daito Pharmaceutical Earnings Date?

Daito Pharmaceutical will release its next earnings report on 09 Oct 2025.

From a Technical Analysis Perspective, Is 4577 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Daito Pharmaceutical Stock Split?

Daito Pharmaceutical has split 3 times.

How Many Employees Does Daito Pharmaceutical Have?

Daito Pharmaceutical has 1070 employees.

What is the current trading status of Daito Pharmaceutical (4577)?

As of 17 Aug 2025, Daito Pharmaceutical (4577) is trading at a price of 1,292.00, with a previous close of 1,273.00. The stock has fluctuated within a day range of 1,273.00 to 1,296.00, while its 52-week range spans from 970.00 to 2,465.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.